Rigel Pharmaceuticals Inc
RIGL· Nasdaq
RIGLRigel Pharmaceuticals Inc
Released Nov 6, 2018, after the close
10-Q filed Nov 6, 2018, 37 days after period end · 0001558370-18-008624
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2018 | Q3 2017 | Q3 2016 | Q3 2015 |
|---|---|---|---|---|
| Revenue | $4.87M | $900.00K | — | — |
| Net Income | -$23.77M | -$17.66M | -$22.63M | — |
| EPS Diluted | -$0.14 | -$0.14 |
Rigel Pharmaceuticals Inc · CIK 1034842 · Engraved from SEC EDGAR
| -$0.24 |
| -$0.08 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
